Nrx Pharmaceuticals earnings were -$24.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest NRXP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.5M, down 39.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, NRXP reported annual earnings of -$25.1M, with -16.7% growth.
Nrx Pharmaceuticals Earnings Reports & History FAQ
What were Nrx Pharmaceuticals's earnings last quarter?
Nrx Pharmaceuticals (NASDAQ: NRXP) reported Q1 2025 earnings per share (EPS) of -$0.34, up 54.05% year over year. Total NRXP earnings for the quarter were -$5.51 million. In the same quarter last year, Nrx Pharmaceuticals's earnings per share (EPS) was -$0.74.
Is Nrx Pharmaceuticals profitable or losing money?
As of the last Nrx Pharmaceuticals earnings report, Nrx Pharmaceuticals is currently losing money. Nrx Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$24.11 million, a 5.96% decrease year over year.
What was NRXP's earnings growth in the past year?
As of Nrx Pharmaceuticals's earnings date in Q2 2025, Nrx Pharmaceuticals's earnings has grown year over year. NRXP earnings in the past year totalled -$24.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.